Beijing Tiantan Biological Products Co., Ltd.
600161
주식 순위
#4320
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
주가
$1.81
시가총액
$3.59B
변동 (1일)
-0.90%
변동 (1년)
-32.39%
국가
CN
거래 Beijing Tiantan Biological Products Co., Ltd. (600161)
카테고리
Healthcare
Beijing Tiantan Biological Products Co., Ltd. (600161)의 수익
2026 기준 수익 TTM: 0
Beijing Tiantan Biological Products Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Beijing Tiantan Biological Products Co., Ltd.의 수익 기록 (2001 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2025 | $260.52M | -25.35% |
| 2024 | $348.98M | 37.34% |
| 2023 | $254.09M | 22.89% |
| 2022 | $206.77M | 5.90% |
| 2021 | $195.25M | 15.45% |
| 2020 | $169.13M | 12.87% |
| 2019 | $149.85M | 18.76% |
| 2018 | $126.18M | -46.94% |
| 2017 | $237.80M | 345.91% |
| 2016 | $53.33M | 74.97% |
| 2015 | $30.48M | -37.81% |
| 2014 | $49.01M | -45.63% |
| 2013 | $90.14M | 26.29% |
| 2012 | $71.38M | 31.58% |
| 2011 | $54.25M | 32.45% |
| 2010 | $40.96M | -20.34% |
| 2009 | $51.42M | 51.23% |
| 2008 | $34.00M | 38.09% |
| 2007 | $24.62M | 53.52% |
| 2006 | $16.04M | 54.94% |
| 2005 | $10.35M | 53.69% |
| 2004 | $6.73M | 8.91% |
| 2003 | $6.18M | 14.01% |
| 2002 | $5.42M | 10.09% |
| 2001 | $4.93M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $1.95B | - |
NL
|
|
| - | - |
CH
|
